Scientific evidence is often invoked late, after key product decisions have already narrowed the available options. When substantiation is treated as a post-hoc exercise, teams may face misalignment between evidence, formulation intent, and claims positioning.
Bringing scientific context into earlier decision-making helps ensure that products can be supported credibly and defended over time.
What This Work Involves
Substantiation extends beyond citing studies. It requires evaluating the relevance, quality, and applicability of evidence to specific ingredients, dosages, delivery formats, and intended uses.
We help teams interpret existing clinical and mechanistic data in context, identify evidentiary gaps, and align substantiation strategy with realistic product and claims objectives.
Where It Fits in the Lifecycle
Clinical and scientific substantiation intersects with formulation strategy, regulatory positioning, and marketing communication. Early consideration helps avoid late-stage constraints, unsupported claims, or mismatches between evidence and product design.
Addressing substantiation early preserves flexibility and reduces downstream compromise.
How We Approach Substantiation
We approach substantiation as an integrative exercise rather than a checklist of citations. Our work considers study design, population relevance, dose translation, and mechanistic plausibility to support claims that are scientifically grounded and contextually appropriate.
The objective is defensibility—clear rationale that can withstand internal review and external scrutiny.
Who This Is For
This work is best suited for teams developing new products, refining claims strategy, or reassessing existing substantiation. It is particularly valuable when products involve emerging ingredients, complex mechanisms, or heightened regulatory and scientific scrutiny.
We may not be the right fit for teams seeking to justify claims without appropriate evidentiary support.